Yuko Toyoda

834 total citations
36 papers, 457 citations indexed

About

Yuko Toyoda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Yuko Toyoda has authored 36 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Rheumatology. Recurrent topics in Yuko Toyoda's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Lung Cancer Treatments and Mutations (10 papers) and Systemic Sclerosis and Related Diseases (6 papers). Yuko Toyoda is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Lung Cancer Treatments and Mutations (10 papers) and Systemic Sclerosis and Related Diseases (6 papers). Yuko Toyoda collaborates with scholars based in Japan, Thailand and United States. Yuko Toyoda's co-authors include Hisatsugu Goto, Hiroshi Kawano, Seidai Sato, Yasuhiko Nishioka, Masaki Hanibuchi, Kazuya Koyama, Jun Kishi, Yoshinori Aono, Yasuhiko Nishioka and Hirohisa Ogawa and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory Cell and Molecular Biology and Oncotarget.

In The Last Decade

Yuko Toyoda

33 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Toyoda Japan 14 288 93 92 88 62 36 457
Johanna Rische Germany 8 231 0.8× 118 1.3× 71 0.8× 67 0.8× 74 1.2× 8 411
Katerina Sfiridaki Greece 11 146 0.5× 107 1.2× 94 1.0× 78 0.9× 20 0.3× 17 376
ST Yuen China 8 180 0.6× 115 1.2× 127 1.4× 80 0.9× 49 0.8× 13 526
Emmanouil Spanoudakis Greece 13 148 0.5× 125 1.3× 129 1.4× 45 0.5× 39 0.6× 49 599
L. Burke United States 8 117 0.4× 67 0.7× 44 0.5× 39 0.4× 111 1.8× 11 374
Tien Anh N. Tran United States 12 142 0.5× 124 1.3× 125 1.4× 25 0.3× 43 0.7× 32 392
Barbara Burroni France 9 109 0.4× 77 0.8× 224 2.4× 77 0.9× 16 0.3× 37 447
Masaki Hiraguri Japan 9 160 0.6× 51 0.5× 40 0.4× 58 0.7× 248 4.0× 15 404
Elisabetta Froio Italy 14 88 0.3× 56 0.6× 189 2.1× 41 0.5× 29 0.5× 38 453
Jane Nguyen United States 12 258 0.9× 175 1.9× 37 0.4× 31 0.4× 69 1.1× 54 401

Countries citing papers authored by Yuko Toyoda

Since Specialization
Citations

This map shows the geographic impact of Yuko Toyoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Toyoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Toyoda more than expected).

Fields of papers citing papers by Yuko Toyoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Toyoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Toyoda. The network helps show where Yuko Toyoda may publish in the future.

Co-authorship network of co-authors of Yuko Toyoda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Toyoda. A scholar is included among the top collaborators of Yuko Toyoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Toyoda. Yuko Toyoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hanibuchi, Masaki, Eiji Takeuchi, Takashi Haku, et al.. (2023). A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer. Thoracic Cancer. 14(32). 3232–3239. 2 indexed citations
3.
Yamakawa, Hideaki, Yuko Toyoda, Tomohisa Baba, et al.. (2022). Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. Journal of Clinical Medicine. 11(13). 3835–3835. 13 indexed citations
4.
Toyoda, Yuko, Eiji Takeuchi, Satoshi Ito, et al.. (2022). Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small‐cell carcinoma: A case report. Thoracic Cancer. 13(23). 3415–3419. 4 indexed citations
5.
Sato, Seidai, Kazuya Koyama, Yajuan Chen, et al.. (2020). Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 63(3). 317–326. 8 indexed citations
6.
Hanibuchi, Masaki, Takuya Kuramoto, Atsuro Saijo, et al.. (2019). Development, validation, and comparison of gene analysis methods for detecting EGFR mutation from non-small cell lung cancer patients-derived circulating free DNA. Oncotarget. 10(38). 3654–3666. 6 indexed citations
7.
Toyoda, Yuko, Kazuya Koyama, Hiroshi Kawano, et al.. (2019). Clinical features of interstitial pneumonia associated with systemic lupus erythematosus. Respiratory Investigation. 57(5). 435–443. 15 indexed citations
8.
Kishi, Masami, Yoshinori Aono, Seidai Sato, et al.. (2018). Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice. PLoS ONE. 13(12). e0209786–e0209786. 40 indexed citations
9.
Murakami, Taichi, Hirokazu Ogino, Motokazu Matsuura, et al.. (2018). Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions. Internal Medicine. 58(5). 679–684. 3 indexed citations
10.
Koyama, Kazuya, Hisatsugu Goto, Seidai Sato, et al.. (2018). The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 60(4). 478–487. 17 indexed citations
11.
Ogino, Hirokazu, Masaki Hanibuchi, Satoshi Sakaguchi, et al.. (2018). The clinical features of older patients with lung cancer in comparison with their younger counterparts. Respiratory Investigation. 57(1). 40–48. 4 indexed citations
12.
Toyoda, Yuko, Hisatsugu Goto, Jun Kishi, et al.. (2018). A case of interstitial pneumonia associated with anti‐PL‐7 antibody in a patient with rheumatoid arthritis. The Journal of Medical Investigation. 65(1.2). 147–150. 1 indexed citations
13.
Hanibuchi, Masaki, Soji Kakiuchi, Shinji Atagi, et al.. (2018). A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease. Lung Cancer. 125. 93–99. 20 indexed citations
14.
Ogino, Hirokazu, Hirohisa Ogawa, Yuko Toyoda, et al.. (2018). A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition. Respiratory Medicine Case Reports. 25. 119–121. 5 indexed citations
15.
Saijo, Atsuro, et al.. (2017). An analysis of the clinical features of lung cancer in patients with connective tissue diseases. Respiratory Investigation. 55(2). 153–160. 10 indexed citations
16.
Sato, Seidai, Shinya Hayashi, Shuichi Abe, et al.. (2017). Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity. Respiratory Research. 18(1). 172–172. 73 indexed citations
17.
Toyoda, Yuko, Masaki Hanibuchi, Jun Kishi, et al.. (2016). Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease.. The Journal of Medical Investigation. 63(3.4). 294–299. 34 indexed citations
18.
Toyoda, Yuko, Sho Tabata, Jun Kishi, et al.. (2013). Thymidine Phosphorylase Regulates the Expression of CXCL10 in Rheumatoid Arthritis Fibroblast‐like Synoviocytes. Arthritis & Rheumatology. 66(3). 560–568. 28 indexed citations
19.
Tabata, Ryo, Nobuhiko Shimizu, Jun Kishi, et al.. (2013). Treatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents. The Journal of Medical Investigation. 60(1.2). 77–90. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Rische Breakdown of academic impact, for papers by Katerina Sfiridaki Breakdown of academic impact, for papers by ST Yuen Breakdown of academic impact, for papers by Emmanouil Spanoudakis Breakdown of academic impact, for papers by L. Burke Breakdown of academic impact, for papers by Tien Anh N. Tran Breakdown of academic impact, for papers by Barbara Burroni Breakdown of academic impact, for papers by Masaki Hiraguri Breakdown of academic impact, for papers by Elisabetta Froio Breakdown of academic impact, for papers by Jane Nguyen
Rankless by CCL
2026